Motor and mental development of infants exposed to antiepileptic drugs in utero (Q46696643)

24 December 2017

title

Motor and mental development of infants exposed to antiepileptic drugs in utero (English)

1 reference

24 December 2017

author name string

Sanjeev V Thomas

1

1 reference

24 December 2017

B Ajaykumar

2

1 reference

24 December 2017

K Sindhu

3

1 reference

24 December 2017

M K C Nair

4

1 reference

24 December 2017

Babu George

5

1 reference

24 December 2017

P S Sarma

6

1 reference

24 December 2017

publication date

17 March 2008

1 reference

24 December 2017

published in

Epilepsy Behavior

1 reference

24 December 2017

volume

13

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

229-236

1 reference

24 December 2017

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Developmental neurotoxicity of anticonvulsants: human and animal evidence on phenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: Animal studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Neuropsychological effects of exposure to anticonvulsant medication in utero

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Minor anomalies in offspring of epileptic mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Intelligence of children of epileptic mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

A transient retardation of early postnatal growth in drug-exposed children of epileptic mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Head circumference in children of epileptic mothers: contributions of drug exposure and genetic background

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Additional educational needs in children born to mothers with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Pregnancy registries in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Folate status of mothers during pregnancy and mental and psychomotor development of their children at five years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Physical and psychomotor development in the offspring born to mothers with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Intelligence and physical features of children of women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

In utero exposure to phenobarbital and intelligence deficits in adult men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Does perinatal phenobarbital exposure affect developmental outcome at age 2?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Children exposed to valproate in utero--population based evaluation of risks and confounding factors for long-term neurocognitive development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Characteristics of fetal anticonvulsant syndrome associated autistic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.01.010

Common antiepileptic drugs in pregnancy in women with epilepsy

7 January 2021

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD004848

Identifiers

DOI

10.1016/J.YEBEH.2008.01.010

1 reference

24 December 2017

PubMed ID

18346940

1 reference

24 December 2017